Diane Weiser | Senior Vice President, Corporate Communications & Investor Relations |
Robert Blum | President & Chief Executive Officer |
Fady Malik | Executive Vice President, Research & Development |
Andrew Callos | Executive Vice President and Chief Commercial Officer |
Stuart Kupfer | Senior Vice President & Chief Medical Officer |
Robert Wong | Vice President & Chief Accounting Officer |
Ching Jaw | Senior Vice President & Chief Financial Officer |
Yasmeen Rahimi | Piper Sandler |
Joe Pantginis | H.C. Wainwright |
Jason Zemansky | Bank of America |
Carter Gould | Barclays |
Tessa Romero | JPMorgan |
Dane Leone | Raymond James |
Jason Butler | JMP Securities |
Charles Duncan | Cantor Fitzgerald |
Justin Kim | Oppenheimer |
Salim Syed | Mizuho |
Serge Belanger | Needham Co |
Madhu Kumar | Goldman Sachs |
Good afternoon and welcome ladies and gentlemen to Cytokinetics' Fourth Quarter 2022 Conference Call. At this time, I would like to inform you that this call is being recorded and that all participants are in a listen-only mode. At the company's request, we will open the call for question-and-answer after the presentation. [Operator Instructions]
I will now turn the call over to Diane Weiser, Cytokinetics' Senior Vice President of Corporate Communications and Investor Relations.